A

who’s-who list of biopharma royalty is headed to the Swiss ski resort town of Davos for four days of hobnobbing this week with politicians, CEOs, and one-percenters from around the globe.

There will be big names like Pfizer’s COO Albert Bourla, Novartis’s incoming CEO Vasant Narasimhan, Roche Chairman Christoph Franz, Illumina’s executive chairman Jay Flatley, and Medtronic’s CEO Omar Ishrak. FDA Commissioner Scott Gottlieb will be there, as will the director of the National Institutes of Health, Francis Collins.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy